» Articles » PMID: 27178527

Antibiotic-Induced Changes in the Intestinal Microbiota and Disease

Overview
Journal Trends Mol Med
Date 2016 May 15
PMID 27178527
Citations 364
Authors
Affiliations
Soon will be listed here.
Abstract

The gut microbiota is a key player in many physiological and pathological processes occurring in humans. Recent investigations suggest that the efficacy of some clinical approaches depends on the action of commensal bacteria. Antibiotics are invaluable weapons to fight infectious diseases. However, by altering the composition and functions of the microbiota, they can also produce long-lasting deleterious effects for the host. The emergence of multidrug-resistant pathogens raises concerns about the common, and at times inappropriate, use of antimicrobial agents. Here we review the most recently discovered connections between host pathophysiology, microbiota, and antibiotics highlighting technological platforms, mechanistic insights, and clinical strategies to enhance resistance to diseases by preserving the beneficial functions of the microbiota.

Citing Articles

A critical review of microbiome-derived metabolic functions and translational research in liver diseases.

Ganesan R, Thirumurugan D, Vinayagam S, Kim D, Suk K, Iyer M Front Cell Infect Microbiol. 2025; 15:1488874.

PMID: 40066068 PMC: 11891185. DOI: 10.3389/fcimb.2025.1488874.


Antibiotic-mediated microbial community restructuring is dictated by variability in antibiotic-induced lysis rates and population interactions.

Kim K, Weiss A, Ma H, Son H, Zhou Z, You L Nat Commun. 2025; 16(1):2299.

PMID: 40055339 PMC: 11889214. DOI: 10.1038/s41467-025-57508-z.


Dietary improves the intestinal functions by regulating the expression of intestinal inflammatory genes and intestinal microbiota in aged laying hens at 80-91 weeks of age.

Dong A, Ding X, Wang J, Zeng Q, Bai S, Liu Y Front Microbiol. 2025; 16:1530319.

PMID: 40041866 PMC: 11877211. DOI: 10.3389/fmicb.2025.1530319.


Concomitant medications in patients with metastatic urothelial carcinoma receiving enfortumab vedotin: real-world data from the ARON-2 study.

Fiala O, Buti S, Fujita K, de Liano A, Fukuokaya W, Kimura T Clin Exp Metastasis. 2025; 42(2):18.

PMID: 39976819 PMC: 11842414. DOI: 10.1007/s10585-025-10335-4.


Antibiotic-associated changes in Akkermansia muciniphila alter its effects on host metabolic health.

Han Y, Teng T, Han J, Kim H Microbiome. 2025; 13(1):48.

PMID: 39920776 PMC: 11804010. DOI: 10.1186/s40168-024-02023-4.


References
1.
Furusawa Y, Obata Y, Fukuda S, Endo T, Nakato G, Takahashi D . Commensal microbe-derived butyrate induces the differentiation of colonic regulatory T cells. Nature. 2013; 504(7480):446-50. DOI: 10.1038/nature12721. View

2.
Bikard D, Euler C, Jiang W, Nussenzweig P, Goldberg G, Duportet X . Exploiting CRISPR-Cas nucleases to produce sequence-specific antimicrobials. Nat Biotechnol. 2014; 32(11):1146-50. PMC: 4317352. DOI: 10.1038/nbt.3043. View

3.
Vetizou M, Pitt J, Daillere R, Lepage P, Waldschmitt N, Flament C . Anticancer immunotherapy by CTLA-4 blockade relies on the gut microbiota. Science. 2015; 350(6264):1079-84. PMC: 4721659. DOI: 10.1126/science.aad1329. View

4.
Dominguez-Bello M, Costello E, Contreras M, Magris M, Hidalgo G, Fierer N . Delivery mode shapes the acquisition and structure of the initial microbiota across multiple body habitats in newborns. Proc Natl Acad Sci U S A. 2010; 107(26):11971-5. PMC: 2900693. DOI: 10.1073/pnas.1002601107. View

5.
Zeevi D, Korem T, Zmora N, Israeli D, Rothschild D, Weinberger A . Personalized Nutrition by Prediction of Glycemic Responses. Cell. 2015; 163(5):1079-1094. DOI: 10.1016/j.cell.2015.11.001. View